Digital Health Global

JANUARY 28, 2025

a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)s PACT Consortium links decentralized clinical trial (DCT) approaches to notably higher participation rates across multiple demographic groups. PALO ALTO, Calif.–(BUSINESS

Drug Development 88

Drug Development Pharmaceuticals Digital Health 88

Lloyd Price

NOVEMBER 16, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Drug Development 73

Drug Development healthcare technology Leadership Life Science 73

Lloyd Price

OCTOBER 14, 2024

Exec Summary: HLTH 2024 Las Vegas is expected to be a major event in the healthcare industry, focusing on innovation, collaboration, and the future of healthcare. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis.

Leadership 57

Leadership healthcare technology Digital Health Mental health 57

Digital Health Global

JANUARY 29, 2025

a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)s PACT Consortium linking decentralized clinical trial (DCT) approaches to notably higher proportional representation among select demographic subgroups. Medable Inc., 5 at 9:55am.

Drug Development 88

Drug Development Pharmaceuticals Digital Health 88

Healthcare IT Today

MARCH 3, 2025

The CRO industry has remained stagnant with extremely limited adoption of technology or modern approaches to streamline clinical development. From 2021 to 2022 alone, the cost of developing a single drug was estimated to have increased by almost $300M.

Life Science 85

Life Science Psychiatry Drug Development Digital Health 85

The Digital Health Corner

MARCH 26, 2018

In this scenario, a patient can digitally determine who should have access to the medical record (and which portion), which person(s) or entities saw or modified the record (and what portion) and when. Herding a patient’s data from many sources into a single record has always been a lofty goal of digital health.

Digital Health 117

Digital Health Interoperability Life Science HIE 117

Digital Health Global

APRIL 5, 2024

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Health Technology 88

Digital Health Global

MAY 10, 2023

The healthcare industry is experiencing a significant transformation, with technology playing a vital role in modernizing medical practices and enhancing health outcomes. Patient experience has become a primary focus in our industry, and the digital transformation has provided new ways to enhance it.

Patient Experience 167

Patient Experience Mobile Health Telemedicine Drug Development 167

Healthcare IT News - Telehealth

MAY 29, 2020

“These technologies can also be leveraged by pharmaceutical companies to monitor the results of the drugs developed by them," said Ashish Kaul, technical insights senior research analyst at Frost & Sullivan. THE LARGER CONTEXT. She cites examples such as Binah.ai ON THE RECORD.

Mental health 179

Mental health Drug Development Pharmaceuticals Telehealth 179

Lloyd Price

DECEMBER 2, 2024

The increasing importance of digital health, coupled with abundant capital and supportive regulatory environments, is likely to drive continued M&A activity and higher valuations. Regulatory Environment: Favourable regulatory policies and increased government support for digital health initiatives are fostering innovation.

Mental health 67

Mental health Digital Health healthcare technology Telehealth 67

Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

Drug Development 128

Drug Development Pharmaceuticals Life Science Digital Health 128

Lloyd Price

OCTOBER 28, 2024

Exec Summary: The healthtech industry, while brimming with potential, faces several significant challenges that hinder its full potential. Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Subscribe Today!

Interoperability 76

Interoperability healthcare technology HIPAA Leadership 76

Lloyd Price

NOVEMBER 8, 2024

Exec Summary: The HealthTech sector is poised for significant M&A activity in 2025, driven by several key trends: Digital Health Solutions: The increasing demand for digital health solutions to improve healthcare accessibility and efficiency will drive acquisitions of innovative startups and established players in this space.

Digital Health 52

Digital Health healthcare technology Pharmaceuticals Telehealth 52

Digital Health Global

MARCH 26, 2024

BASEL, Switzerland–(BUSINESS WIRE)–Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digital health technology and develop digital biomarkers for Parkinson’s disease.

Health Technology 88

Health Technology Digital Health BioTech Drug Development 88

Healthcare IT Today

JANUARY 7, 2025

As these implementations take hold, the emphasis will be on demonstrating measurable return on investment (ROI), with AI driving down administrative burdens, accelerating drug development, and significantly improving operational efficiency. That progress will accelerate in 2025 and prove to be one of the most beneficial AI use cases.

Health IT 93

Health IT Life Science Drug Development Pharmaceuticals 93

Digital Health Global

NOVEMBER 20, 2023

–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. in 2060.

Life Science 88

Life Science Drug Development Digital Health Patient Experience 88

Digital Health Global

MARCH 2, 2023

Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Lloyd Price

JULY 15, 2024

Exec Summary: Digital Health is a subset of Healthtech. Digital Health focuses on the individual patient, while Healthtech focuses on the entire healthcare ecosystem. Artificial intelligence: This is a rapidly developing field that has the potential to revolutionize healthcare. Subscribe Today!

Digital Health 62

Digital Health Mobile Health Telehealth Mental health 62

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners.

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Lloyd Price

JANUARY 20, 2025

In the context of healthtech and digital health, it means a company initially targets consumers (B2C), builds a strong user base, and then leverages this consumer adoption to attract businesses (B2B), such as insurers, employers, or healthcare providers. Exec Summary: B2C2B stands for Business-to-Consumer-to-Business.

Mental health 62

Mental health healthcare technology Telehealth Digital Health 62

Digital Health Global

JUNE 13, 2023

“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Lloyd Price

DECEMBER 2, 2024

Here are some key trends and developments to watch: Key Trends: Technological Advancements: New technologies are revolutionizing wound care, including advanced wound dressings, bioengineered skin substitutes, and innovative wound management devices. This shift towards digitalisation is improving patient outcomes and reducing healthcare costs.

Digital Health 57

Digital Health healthcare technology Telemedicine Leadership 57

Society for Participatory Medicine

JANUARY 27, 2022

The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care. Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users.

BioTech 97

BioTech Life Science Drug Development Patient Experience 97

Digital Health Global

JANUARY 8, 2024

AI-powered* platform takes eCOA off the critical path to study startup for life sciences industry PALO ALTO, Calif.–(BUSINESS Early application of the technology in electronic clinical outcomes assessment (eCOA) deployments – a major delay to study startup industry-wide – is groundbreaking.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Lloyd Price

FEBRUARY 20, 2020

At Mangrove, we believe digital health represents one of the very largest opportunities for value creation. It will also explain the value of clinically- proven software interventions, while dispelling the myth that doctors are better placed to build digital health businesses.

mHealth 85

mHealth Drug Development Digital Health 85

Lloyd Price

SEPTEMBER 16, 2024

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML are revolutionising the healthcare industry, from drug discovery to patient diagnosis and treatment. Biopharma Innovation and Drug Development: The development of innovative drugs and therapies remains a key focus in the healthcare industry.

Digital Health 67

Digital Health Drug Development healthcare technology Leadership 67

Healthcare IT Today

NOVEMBER 1, 2022

Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.

Life Science 105

Life Science Drug Development Digital Health Health IT 105

Digital Health Global

MAY 29, 2024

the leading technology provider for modern clinical trials, is partnering with industry leader Masimo (NASDAQ: MASI) to bring best-in-class medical-grade wearable devices to clinical research. Partnership enables deeper evidence generation in clinical trials; early success in eight big-pharma-sponsored oncology studies PALO ALTO, Calif.–(BUSINESS

Drug Development 88

Drug Development Digital Health 88

Xealth

JUNE 27, 2023

David Slifka, Vice President, Commercial Enablement The digital health ecosystem is a complex place. Confusion abounds among healthcare providers regarding digital therapeutics (DTx) terminology and classifications, and understandably so. DTx fall within the digital medicine subset within the larger digital health ecosystem.

Digital Health 52

Digital Health Drug Development Pharmaceuticals Nursing 52

Digital Health Global

APRIL 16, 2024

Innovative and flexible, Medable Total Consent helps our industry move beyond simply relying on traditional paper consents.” Its digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure. Renal Care.

Drug Development 88

Drug Development Pharmaceuticals Health science Digital Health 88

Digital Health Global

SEPTEMBER 27, 2023

About Automera Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. ALSP’s portfolio companies are backed by renowned life science investors and are comprised of industry-leading, transformative companies, including KayoThera, Inc.,

Life Science 88

Life Science Drug Development HC BioTech 88

Digital Health Global

AUGUST 22, 2024

Spellman and Wortel are the most recent additions to Catawba Research’s team of scientific and regulatory advisors who support sponsors across a multitude of therapeutic areas and provide clinical development and regulatory strategy across North America, Europe and Asia. Mary earned her M.D.

Leadership 88

Leadership Pharmaceuticals Drug Development Digital Health 88

Lloyd Price

NOVEMBER 21, 2023

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. b) Build: develop new products for the 4P's? Subscribe Today!

Drug Development 73

Drug Development Health science healthcare technology Leadership 73

Healthcare IT Today

JULY 25, 2022

AI/ML is revolutionizing the healthcare industry,” said Schiess. The most advanced teams spend precious time developing internal tools to tackle aspects of this issue, but rarely have the staff, focus or time to create a comprehensive solution. But in order for an AI system to work, datasets must be complete, and they must be accurate.

Life Science 98

Life Science Drug Development Digital Health Health Data 98

Lloyd Price

JUNE 17, 2023

The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.

Digital Health 83

Digital Health Drug Development Telemedicine Telehealth 83

Digital Health Global

JANUARY 31, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment of on average of $500K in Phase 2 and $1.5M in Phase 3.

Health science 88

Health science Drug Development Digital Health Patient Experience 88

Lloyd Price

DECEMBER 11, 2023

Health Tech founder and M&A Advisor Lloyd Price believes virtual care can bring a sweep of benefits, but cautions that it will still need to find a way through barriers around access and affordability for patients, the security of patient data and the licensing of healthcare providers to practice across geographical and care boundaries.

Pharmaceuticals 67

Pharmaceuticals Digital Health Drug Development Life Science 67